F. Geurs

953 total citations
11 papers, 687 citations indexed

About

F. Geurs is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, F. Geurs has authored 11 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in F. Geurs's work include Bone health and treatments (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Gastric Cancer Management and Outcomes (3 papers). F. Geurs is often cited by papers focused on Bone health and treatments (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Gastric Cancer Management and Outcomes (3 papers). F. Geurs collaborates with scholars based in Belgium, United Kingdom and United States. F. Geurs's co-authors include Pirow Bekker, Allan Lipton, Robert E. Coleman, Donna Holloway, Thierry Façon, Jean-Jacques Body, Michelle Fan, Mark Peterson, Jean‐Luc Harousseau and Jean‐Jacques Body and has published in prestigious journals such as Cancer, Clinical Cancer Research and Age and Ageing.

In The Last Decade

F. Geurs

10 papers receiving 657 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Geurs Belgium 5 584 321 158 158 129 11 687
Evgenia Verrou Greece 13 916 1.6× 210 0.7× 84 0.5× 501 3.2× 469 3.6× 32 1.1k
Raffaello Bertieri Italy 7 264 0.5× 88 0.3× 53 0.3× 46 0.3× 275 2.1× 7 766
Hiroyuki Yonou Japan 14 263 0.5× 247 0.8× 82 0.5× 20 0.1× 23 0.2× 27 547
G.H. Borgström Finland 16 173 0.3× 174 0.5× 80 0.5× 39 0.2× 587 4.6× 24 919
Sonia Ronconi Italy 17 479 0.8× 574 1.8× 33 0.2× 59 0.4× 836 6.5× 40 1.1k
Gian-Matteo Pica Italy 8 418 0.7× 230 0.7× 20 0.1× 62 0.4× 438 3.4× 16 729
Kyoko Haraguchi Japan 9 99 0.2× 69 0.2× 116 0.7× 92 0.6× 132 1.0× 27 457
Kevin Forsythe United States 10 78 0.1× 56 0.2× 29 0.2× 91 0.6× 129 1.0× 13 426
Tanya Taran United States 11 603 1.0× 226 0.7× 51 0.3× 164 1.0× 11 0.1× 31 747
Jakob Werner Hansen Denmark 13 264 0.5× 216 0.7× 32 0.2× 11 0.1× 218 1.7× 39 822

Countries citing papers authored by F. Geurs

Since Specialization
Citations

This map shows the geographic impact of F. Geurs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Geurs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Geurs more than expected).

Fields of papers citing papers by F. Geurs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Geurs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Geurs. The network helps show where F. Geurs may publish in the future.

Co-authorship network of co-authors of F. Geurs

This figure shows the co-authorship network connecting the top 25 collaborators of F. Geurs. A scholar is included among the top collaborators of F. Geurs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Geurs. F. Geurs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Vandendriessche, Benjamin, et al.. (2012). Raltitrexed + irinotecan as second-line chemotherapy in elderly patients with advanced colorectal cancer. 1(2). 5–10. 2 indexed citations
2.
3.
Geurs, F., et al.. (2010). Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient. International Journal of Nephrology and Renovascular Disease. 3. 61–61.
4.
Geurs, F., et al.. (2008). Successful and Well-Tolerated Second Line Therapy with Cetuximab, Irinotecan, and Raltitrexed in Progressive Liver Disease Due to Metastatic Colon Cancer. Journal of Gastrointestinal Cancer. 39(1-4). 26–28. 2 indexed citations
5.
6.
Body, Jean-Jacques, Thierry Façon, Robert E. Coleman, et al.. (2006). A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.. Clinical Cancer Research. 12(4). 1221–1228. 348 indexed citations
7.
Body, Jean‐Jacques, Philip R. Greipp, Robert E. Coleman, et al.. (2003). A Phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases. Cancer. 97(S3). 887–892. 295 indexed citations
8.
Geurs, F., et al.. (1997). A simple and efficient urine sampling method for bacteriological examination in elderly women. Age and Ageing. 26(6). 493–495. 10 indexed citations
9.
Kerger, Joseph, Ahmad Awada, F. Geurs, et al.. (1997). Mitomycin C and Vinblastine in combination with Amifostine in metastatic breast cancer. Supportive Care in Cancer. 5(5). 414–416. 6 indexed citations
10.
Neste, Eric Van Den, Joseph Kerger, Dominique de Valeriola, et al.. (1996). Phase I clinical study of Docetaxel (TXT) in combination with continuous infusion (CI) Fluorouracil (5-FU) in patients (pts) with advanced solid tumors. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 168. 1 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evgenia Verrou Breakdown of academic impact, for papers by Raffaello Bertieri Breakdown of academic impact, for papers by Hiroyuki Yonou Breakdown of academic impact, for papers by G.H. Borgström Breakdown of academic impact, for papers by Sonia Ronconi Breakdown of academic impact, for papers by Gian-Matteo Pica Breakdown of academic impact, for papers by Kyoko Haraguchi Breakdown of academic impact, for papers by Kevin Forsythe Breakdown of academic impact, for papers by Tanya Taran Breakdown of academic impact, for papers by Jakob Werner Hansen
Rankless by CCL
2026